With extensive expertise in the healthcare and biotechnology sectors, the fund manager has successfully executed over 30 deals across Japan and the broader Asia-Pacific region. Their strategic approach emphasizes a data-driven investment style, focusing on early and growth stage opportunities. Notable exits include several high-profile companies that have significantly contributed to advancements in medical technology. This operator-first mindset allows for a deep understanding of the market, fostering strong partnerships and innovative solutions within the industry.